Synthesis of Bio-Active Silver Nanoparticles against Human Lung Cancer Cell Line (A549) with Little Toxicity to Normal Cell Line (WRL68).

Nanomaterials are characterized by mechanical, thermal, chemical, biological, and other properties that are different from the basic materials that make them up due to their large surface area to size ratio and quantum effect. There are multiple ways to produce nanomaterials mechanically, chemically, and physically, but they are not safe for the environment. Researchers have sought to find safe methods for the production of nanomaterials, such as green manufacturing, that is, manufacturing nanomaterials from plants. Moreover, there are other sources, such as bacteria or fungi that are used in the production of nanomaterials. This study aimed to try to find an alternative to chemically manufactured drugs, such as those used in the treatment of human cancers, through nanotechnology and from plant sources (green-biosynthesis), which is characterized by abundance and low economic cost. Silver nanoparticles were green-synthesized using an aqueous extract of the licorice plant, their properties were diagnosed, and their differences with the crude aqueous extract were determined. The sizes of nanoparticles were within the range of 60.27-89.80 nm, while the sizes of the crude aqueous extract particles were within the range of 53.96-113.1 nm. Atomic force microscopy was used to find out the shapes, topography, roughness, and protrusions of the surfaces of biosynthesized AgNPs and aqueous extract particles, where the roughness rate of the nanoparticles was 75.54 nm, while it appeared. In vitro test of AgNPs showed a higher anti-lung cancer activity against the A549 cell line than that of the extract at an inhibitory concentration for half of the cells used in the experiment (IC50) of 58.78 µg/ml while the IC50 of the extract was 67.44 µg/ml. The results showed that the toxicity of AgNPs on the normal hepatocyte line (WRL68) was less than that of the aqueous extract, with IC50 concentrations of 244.2 and 147.0 µg/ml, respectively. It is worth mentioning that the lower IC50 led to higher toxicity.

Extended-spectrum beta-lactamase (ESBL) producing and multidrug-resistant Escherichia coli in street foods: a public health concern.

Antimicrobial resistance (AMR) pattern and virulence genes of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from foods of animal origin were evaluated. Based on combination disc method and ESBL E test, 42 of the 213 E. coli isolates were confirmed as ESBL producers where a high presence was observed in raw foods (60.62%), environmental samples (46.73%) and ready to eat foods (42.99%) of which 31(26.49%), 3(6.97%) and 7(15.21%) samples harbored ESBL E. coli, respectively. Higher contamination rates were observed in samples collected from meat vendors (54.36%), milk vendors (48.88%) and egg vendors (45.20%) of which 16.1%, 11.11% and 2.05%, respectively were ESBL E. coli. Among the 42 ESBL isolates, 85.71% (36/42) were multidrug-resistant. On polymerase chain reaction (PCR) analysis, expression of beta-lactamase genes viz., blaCTXM was noted in 69.04% (29/42) ESBL isolates, blaTEM in 66.66% (28/42) and blaOXA-1 in 19.04% (8/42) isolates, while blaSHV was not detected in any of the isolates. Other AMR genes viz., blaAmpC, sul1, sul2, tet(A), tet(B), catI, dhfrI, aac(3)-IIa(aacC2), aph(3')-Ia(aphA1), qnrB, qnrS were detected by PCR in 39, 28, 29, 3, 9, 5, 17, 11, 6, 6 and 33 isolates, respectively. None of the isolates harbored chloramphenicol (floR) and plasmid-mediated quinolone resistance (PMQR) (qnrA) genes. However, 21 isolates were positive for class I integron (int1), 5 for EPEC (eae) and 9 for ETEC (lt) while none were carrying bfp or stII genes. All ESBL producing isolates formed a single group when subjected to enterobacterial repetitive intergenic consensus (ERIC PCR) genotyping. The presence of multidrug-resistant ESBL E. coli in street foods of animal origin raises the issues of food safety and public health.